NanoVibronix Inc. has announced a new Securities Purchase Agreement with an institutional investor, dated July 18, 2025. As part of this agreement, NanoVibronix will sell 8,889 shares of its newly-designated Series H Convertible Preferred Stock, valued at $1,000 per share, and warrants for up to 4,678,363 shares of common stock. This transaction, which closed on July 22, 2025, raised $8 million in gross proceeds. The company plans to use $5 million to redeem Series X Preferred Stock and allocate the remainder for working capital. The agreement requires stockholder approval for issuing shares beyond 19.99% of current common stock at prices below Nasdaq's minimum price rules.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.